BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Leukocyte
,
Avian flu virus
,
Ciprofibrate
,
rs4950928
,
SNCA
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tat- gene
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ T cells expressing constitutively full-length or first-exon Tat protein of HIV-1
Neuronal cortical cultures treated with HIV recombinant TAT (1–86), DDX3 inhibitor RK33 & cocaine
Chronic myeloid leukemia RPMI8866 cells ectopically expressing HIV-1 mutant TAT C22G protein
T lymphocytes treated with HIV Tat protein
Dendritic cells expressing HIV-1 Tat alleles and mutants
Explore Curated Studies Results
Literature
Most Relevant Literature
TAT gene polymorphism and its relationship with production traits in Muscovy ducks (Cairina Moschata…
Genetic stability of SIV Gag/Tat gene inserted into Del-II in modified vaccinia virus ankara after s…
Knockout of Tyrosine Aminotransferase Gene by Homologous Recombination Arrests Growth and Disrupts R…
HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.
Tyrosinemia type II: novel mutations in the TAT gene in a boy with unusual presentation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infec…
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patient…
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted E…
Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ